Class IIOngoing

Vasostrict (vasopressin in 5% Dextrose) Injection recall

FDA recall D-0232-2024 · initiated Jan 11, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Details

Product: Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
Recalling company: Par Sterile Products
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide USA
Initiated: Jan 11, 2024
FDA report date: Jan 24, 2024

This recall is linked to a product we cover: Vasostrict →

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0232-2024 ↗

← All drug recalls